Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases (Q34563117)

3 August 2017

title

Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases (English)

1 reference

3 August 2017

1 reference

Andrea T Deyrup

1

1 reference

3 August 2017

Maria Tretiakova

series ordinal

2

1 reference

3 August 2017

Anthony G Montag

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

106

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

208-213

1 reference

The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

The desmoid tumor. III. A biochemical and genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Immunolocalisation of oestrogen receptor beta in human tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Desmoids in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Estrogen and antiestrogen binding sites in desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Juvenile fibromatosis: hormonal receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Oestrogen and progesterone receptor expression in mammary fibromatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Selective oestrogen receptor modulators in desmoid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: a preliminary report.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Prognostic factors for fibromatoses: A correlation of proliferation index, estrogen receptor, p53, retinoblastoma, andsrc gene products and clinical features with outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Desmoid tumours treated with triphenylethylenes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Treatment of Desmoids and Mesenteric Fibromatosis in Familial Adenomatous Polyposis with Raloxifene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Response of estrogen receptor-positive intraabdominal fibromatosis to aromatase inhibitor therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Endocrine therapy for desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Sequential treatment of recurrent mesenteric desmoid tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Indomethacin and ascorbate inhibit desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Antiestrogen binding sites: general and comparative properties

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Multiple targeting by the antitumor drug tamoxifen: a structure-activity study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Synthesis and secretion of transforming growth factor-beta1 by human desmoid fibroblast cell line and its modulation by toremifene.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Superficial fibromatoses are genetically distinct from deep fibromatoses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Biotin-rich, optically clear nuclei express estrogen receptor-beta: tumors with morules may develop under the influence of estrogen and aberrant beta-catenin expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Wnt/beta-catenin and estrogen signaling converge in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21553

7 January 2021

Identifiers

DOI

10.1002/CNCR.21553

1 reference

3 August 2017

1 reference